Moreover, the quantity of FLJ10540 in cells could serve as a critical mediator of VEGF-A-dependent biological events through activation of the PI3K/AKT signaling pathway, resulting in the progression of lung adenocarcinoma. This evidence concerns the gene AKT1 and lung adenocarcinoma.